Chennai (Tamil Nadu) [India], June 29: Kauvery Heart Institute, the center of excellence in comprehensive cardiac services at Kauvery Hospital - Radial Road, Kovilambakkam, proudly announces the launch of the latest AI-based Ultreon Coronary Imaging system. By acquiring this ground-breaking
According to new research presented at the British Cardiovascular Society conference, consuming beetroot juice daily for six months following the insertion of a stent reduced the probability that angina patients would have a heart attack or require repeat treatment.
According to recent research presented at the British Cardiovascular Society conference, drinking beetroot juice daily for six months following the placement of a stent decreased the likelihood that angina patients would experience a heart attack or require a repeat treatment.
Geneva [Switzerland], May 31: 12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular Treatment (JET) Conference in Tokyo. The objective of this study was to assess the safety and efficacy of SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloo
Jaipur (Rajasthan) [India], May 18 (ANI/BusinessWire India): For the first time in the country, such a technique of angioplasty was used in the calcified blockage of the artery of the heart, in which the blockage was cleaned with a drill moving like the axis of the solar system (orbital athe
New Delhi [India], March 17 (ANI/SRV): A, 68 years old, a follow-up patient for 10 years, recently started to have frequent episodes of angina. A known diabetic and hypertensive for 15 years, he had a heart attack, and Dr Sameer Kubba, Director, Clinical & Interventional Cardiology, Max
Geneva [Switzerland], March 15 (ANI/PRNewswire): MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now a third of the way towards the target of 3,326 patients. SELUTION DeNovo compares the treatment st
Geneva [Switzerland], January 26 (ANI/PRNewswire): The first US patient has been enrolled at MedStar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to support FDA approval. This milestone follows Investigational Device Exemption (IDE) approval in the US i
Geneva [Switzerland], January 11 (ANI/PRNewswire): SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.
The plea stated that at present cardiac stents or coronary stents are allowed to be manufactured or imported and sold, without or with negligible supporting clinical study or data, and merely based on predicate (device or literature), submitted by the manufacturer or importer.
For the first time in Jammu and Kashmir, doctors performed an airway stenting procedure (Y-SEMS Tracheobronchial stent) with a flexible video bronchoscope system at Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Soura.